0001181431-13-041158.txt : 20130723 0001181431-13-041158.hdr.sgml : 20130723 20130723190909 ACCESSION NUMBER: 0001181431-13-041158 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130723 FILED AS OF DATE: 20130723 DATE AS OF CHANGE: 20130723 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROOT JONATHAN D CENTRAL INDEX KEY: 0001225480 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 13982225 MAIL ADDRESS: STREET 1: 2735 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 rrd385949.xml X0306 4 2013-07-23 0 0001302573 OncoMed Pharmaceuticals Inc OMED 0001225480 ROOT JONATHAN D 2735 SAND HILL ROAD MENLO PARK CA 94025 1 0 1 0 Common Stock 2013-07-23 4 C 0 1028381 A 1028381 I Directly owned by USVP VIII Common Stock 2013-07-23 4 C 0 1215407 A 2243788 I Directly owned by USVP VIII Common Stock 2013-07-23 4 C 0 1505032 A 3748820 I Directly owned by USVP VIII Common Stock 2013-07-23 4 P 0 155164 17.00 A 3903984 I Directly owned by USVP VIII Common Stock 2013-07-23 4 C 0 9505 A 9505 I Directly owned by EP VIII-A Common Stock 2013-07-23 4 C 0 11233 A 20738 I Directly owned by EP VIII-A Common Stock 2013-07-23 4 C 0 13910 A 34648 I Directly owned by EP VIII-A Common Stock 2013-07-23 4 P 0 1434 17.00 A 36082 I Directly owned by EP VIII-A Common Stock 2013-07-23 4 C 0 4817 A 4817 I Directly owned by EP VIII-B Common Stock 2013-07-23 4 C 0 5694 A 10511 I Directly owned by EP VIII-B Common Stock 2013-07-23 4 C 0 7051 A 17562 I Directly owned by EP VIII-B Common Stock 2013-07-23 4 P 0 727 17.00 A 18289 I Directly owned by EP VIII-B Common Stock 2013-07-23 4 C 0 9926 A 9926 I Directly owned by AFF VIII Common Stock 2013-07-23 4 C 0 11731 A 21657 I Directly owned by AFF VIII Common Stock 2013-07-23 4 C 0 14527 A 36184 I Directly owned by AFF VIII Common Stock 2013-07-23 4 P 0 1498 17.00 A 37682 I Directly owned by AFF VIII Series A Preferred Stock 2013-07-23 4 C 0 1028381 D Common Stock 1028381 0 I Directly owned by USVP VIII Series A Preferred Stock 2013-07-23 4 C 0 9505 D Common Stock 9505 0 I Directly owned by EP VIII-A Series A Preferred Stock 2013-07-23 4 C 0 4817 D Common Stock 4817 0 I Directly owned by EP VIII-B Series A Preferred Stock 2013-07-23 4 C 0 9926 D Common Stock 9926 0 I Directly owned by AFF VIII Series B Preferred Stock 2013-07-23 4 C 0 1215407 D Common Stock 1215407 0 I Directly owned by USVP VIII Series B Preferred Stock 2013-07-23 4 C 0 11233 D Common Stock 11233 0 I Directly owned by EP VIII-A Series B Preferred Stock 2013-07-23 4 C 0 5694 D Common Stock 5694 0 I Directly owned by EP VIII-B Series B Preferred Stock 2013-07-23 4 C 0 11731 D Common Stock 11731 0 I Directly owned by AFF VIII Series B-1 Preferred Stock 2013-07-23 4 C 0 1505032 D Common Stock 1505032 0 I Directly owned by USVP VIII Series B-1 Preferred Stock 2013-07-23 4 C 0 13910 D Common Stock 13910 0 I Directly owned by EP VIII-A Series B-1 Preferred Stock 2013-07-23 4 C 0 7051 D Common Stock 7051 0 I Directly owned by EP VIII-B Series B-1 Preferred Stock 2013-07-23 4 C 0 14527 D Common Stock 14527 0 I Directly owned by AFF VIII Each share of Series A, Series B and Series B-1 Preferred Stock automatically converted on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering on July 23, 2013. The reported securities are owned directly by each of U.S. Venture Partners VIII, L.P. ("USVP VIII"), USVP VIII Affiliates Fund, L.P. ("AFF VIII"), USVP Entrepreneur Partners VIII-A, L.P. ("EP VIII-A") and USVP Entrepreneur Partners VIII-B, L.P. ("EP VIII-B" and together with USVP VIII, AFF VIII and EP VIII-A, the "USVP Funds"). Presidio Management Group VIII, LLC, or PMG VIII, is the general partner of the USVP Funds, and may be deemed to have sole voting and dispositive power over the shares held by the USVP Funds. PMG VIII and Irwin Federman, Winston Fu, Steven Krausz, David Liddle, Jonathan Root, Christopher Rust, Casey Tansey and Philip Young, the managing members of PMG VII, who may be deemed to share voting and dispositive power over the reported securities, disclaim beneficial ownership of the reported securities held by the USVP Funds except to the extent of any pecuniary interest therein. The securities are immediately convertible. The expiration date is not relevant to the conversion of these securities. /s/ Yvonne Li, Attorney-in-Fact for Jonathan D. Root 2013-07-23